主 办:北 京 中 医 药 大 学
ISSN 1006-2157 CN 11-3574/R

JOURNAL OF BEIJIGN UNIVERSITY OF TRADITIONAL CHINE ›› 2015, Vol. 38 ›› Issue (2): 139-144.doi: 10.3969/j.issn.1006-2157.2015.02.015

Previous Articles    

Efficacy of fitness qigong Ba Duan Jin in pulmonary rehabilitation of patients with chronic obstructive pulmonary disease at stable stage*

XUE Guang-wei12, FENG Cui-ling1#, YAO Xiao-qin1,QI Ying1, WANG Yan-ning3, MA Jia4   

  1. 1 Respiratory Department, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700;
    2 Respiratory Department, Rizhao Hospital of Traditional Chinese Medicine;
    3 Qingshuiyuan Community Health Service Station;
    4 Haiyuncang Community Health Service Station
  • Received:2014-08-06 Online:2015-02-28 Published:2015-02-28

Abstract: Objective To investigate the efficacy of fitness qigong Ba Duan Jin in pulmonary rehabilitation of patients with chronic obstructive pulmonary disease (COPD) at stable stage. Methods The patients who met the diagnosis criteria were randomly divided into Ba Duan Jin group (n=31) and control group (n=28). Patients in the control group received conventional pharmacotherapy, while patients in the Ba Duan Jin group practiced fitness qigong Ba Duan Jin on the basis of using the conventional pharmacotherapy. The duration of the study lasted for 180 days. On the 1st day and the 180th day, COPD assessment test (CAT),lung function test, and acute exacerbation frequency test were performed. Results Fitness qigong Ba Duan Jin significantly improved the sum of CAT scores and scores of single symptoms(P<0.05); Fitness qigong Ba Duan Jin seemed to increase FVC of grade A patients and slow down the descending rate of FEV1 and FEV1/FVC of grade B patients(P<0.05). Conclusion On the basis of using the conventional pharmacotherapy, fitness qigong Ba Duan Jin can relieve the symptoms of patients, increase their exercise tolerance, and improve their quality of life at the stable stage of COPD.

Key words: pulmonary rehabilitation, fitness qigong Ba Duan Jin, COPD, stable stage

CLC Number: 

  • R256.14